TCL Archive Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.) April 2, 2010
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
TCL Archive NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use December 7, 1984
